MyoAAV-3A Serotype
Third myoAAV variant with enhanced cardiac muscle tropism within the muscle-targeted series.
| Tropism | Cardiac muscle (enhanced), skeletal muscle, cross-species validated |
|---|
Characteristics
M-CREATE evolved with cardiac emphasis. Strong cardiomyocyte transduction. Maintained skeletal muscle targeting. Cross-species efficacy demonstrated. Favorable safety profile.
Applications
Cardiac gene therapy. Heart failure treatments. Cardiomyopathies with systemic delivery.
Sequence1 bp
Sign in to view the full sequence.
Sign inReferences
- 1.Tabebordbar et al. (2021). Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell — Tabebordbar 2021 MyoAAV
